Margarida D Amaral, PhD is an expert in Biochemistry at Hospital Recoletas Campo Grande (Spain). As of August 2026, ScienceLeadR ranks Margarida D Amaral in the top 1% of experts worldwide for Cystic Fibrosis and Pancreatic Diseases. Margarida D Amaral has authored 192 publications, the most recent in 2026. SLR score: 659 (community average: 125). How the SLR is computed.

LeadR Profile

Margarida D Amaral, PhD Hospital Recoletas Campo Grande Spain
659 ScienceLeadR Reputation 659
Network Map

Biochemistry

Subspecialties: Nephrology - Pharmacy - Pulmonology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2002 - 2026

Source: PubMed

Lusíada University of Lisbon

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 192

Citations

Citations: 7 632 1st author: 23 Last author: 69 Unique author: 9


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Combining Gene Therapy with Current Modulator Treatments for Cystic Fibrosis: A Promising Area of Research.
PMID 42654157 — genes, fibrosis, cystic fibrosis, nucleic acids, research, therapeutics
Pharmaceutics20260
A functional comparison of vanzacaftor/tezacaftor/deutivacaftor and elexacaftor/tezacaftor/ivacaftor in patient-derived intestinal organoids with rare CFTR variants.
PMID 42303492 — cystic fibrosis, organoids, genotype
J Cyst Fibros20262
ECFS statement on theratyping and theranostics in the context of rare and ultrarare CFTR variants in people with CF.
PMID 42097909 — cells, pharmaceutical preparations, cystic fibrosis, genotype, therapeutics
J Cyst Fibros20260
Investigation of HE4 expression concerning epithelial-mesenchymal transition (EMT) in cystic fibrosis epithelial cells.
PMID 41936498 — cells, fibrosis, epithelial-mesenchymal transition, epithelial cells, phenotype, cadherins, cystic fibrosis, therapeutics
J Cyst Fibros20260
Author's Reply to Yang and Wang: "Personalized Medicine in Cystic Fibrosis: Characterization of Eight Rare CFTR Variants in Intestinal Organoids and Cellular Models".
PMID 41591706 — fibrosis, molecular diagnostic techniques, cystic fibrosis, organoids, precision medicine
Mol Diagn Ther20260

LeadR Networks

Main global connection map